Utah People's Post

The Latest News from the Beehive State

Monday, January 18, 2021
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / Acamprosate and Oral Naltrexone drugs effective in treating alcohol use disorders

Acamprosate and Oral Naltrexone drugs effective in treating alcohol use disorders

Posted by

A new study has revealed that the doubtful medications acamprosate and oral naltrexone are effective in treating alcohol use disorders (AUDs). The study also found that the more prominent drug disulfiram has little to no effect in treating the condition.

The study was funded by the Department of Health and Human Services.

The patients suffering through the alcoholism problem often switch to medications when behavioral therapies and mutual-help groups (such as A.A.) fail to treat their condition.

In a statement, the authors said, “When clinicians decide to use one of the medications, a number of factors may help with choosing which medication to prescribe, including the medication’s efficacy, administration frequency, cost, adverse events, and availability.”

400041-binge-drinking

Dr. Daniel E. Jonas of the University of North Carolina led a study that reviewed 123 research works. The researchers evaluated the possible benefits and harmful side effects of AUD medication.

Some of the FDA-approved medications for AUD included in this meta-analysis were disulfiram, acamprostate, both injectable and oral naltrexone, nalmefene and topiramate.

Considering its availability since the 1950s, disulfiram is a more recognizable treatment for physicians and patients compared to acamprosate and naltrexone.

According to the scientists, the effectiveness for each medication was represented by a number needed to treat (NNT) point system. Under this system, benefit in one patient was represented through the average number of patients who need to be treated.

Findings of the study

  • Acamprostate yielded an NNT of 12 for preventing a return to any drinking compared to oral naltrexone at 20.
  • No evidence supporting injectable naltrexone or disilfiram’s ability to prevent a return to any drinking or heavy drinking was found.
  • Nalmefene and topiramate showed some success in improving consumption outcomes.
  • Oral naltrexone also scored a 12 NNT for preventing a return to heavy drinking.

Dr. Katharine A. Bradley from the Group Health Research Institute and Dr. Daniel R. Kivlahan from the Veterans Health Administration in an accompanying editorial said,  “Treatment of AUD is considered an essential health benefit under health care reform. More patients with AUDs will have insurance, which could increase their access to evidence-based treatments for AUDs. The article by Jonas and colleagues should encourage patients and their clinicians to engage in shared decision making about AUD treatment options.”

The National Institute on Alcohol Abuse and Alcoholism report says about 18 million Americans suffer from an alcohol use disorder including alcohol dependence (alcoholism) or alcohol abuse.

The work has been published in the Journal of the American Medical Association ( JAMA ).

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health Tagged With: Acamprosate, alcohol problem, alcoholism problem, disulfiram, medication for alcoholics, oral naltrexone

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

By

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

By

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

By

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

By

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

By

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

By

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

By

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

By

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

By

456 People Dead at U.K. Hospital after Taking too Many Painkillers

By

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

By

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

  • Our Brains Are Craving Combinations of Fats and Carbs (Study)

  • Hungry bird with beck open

    Scientists Explain Why We Get ‘Hangry’

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2021 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This website uses cookies to ensure you get the best experience on our website. Learn more.